Business Description
Regentis Biomaterials Ltd
ISIN : IL0012190968
Total Employee Number:
8Description
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.16 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | -0.09 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -337.8 | |||||
3-Year EPS without NRI Growth Rate | -312.9 | |||||
3-Year FCF Growth Rate | -103 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.64 | |||||
9-Day RSI | 46.02 | |||||
14-Day RSI | 49.15 | |||||
3-1 Month Momentum % | -52.31 | |||||
6-1 Month Momentum % | -77.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.65 | |||||
Quick Ratio | 2.65 | |||||
Cash Ratio | 2.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | -37.28 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -477.48 | |||||
ROIC % | -178.41 | |||||
3-Year ROIIC % | 939.06 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 3.14 | |||||
Price-to-Tangible-Book | 3.14 | |||||
EV-to-EBIT | -1.06 | |||||
EV-to-EBITDA | -1.06 | |||||
EV-to-FCF | -10.27 | |||||
| Price-to-Net-Current-Asset-Value | 3.14 | |||||
| Price-to-Net-Cash | 3.32 | |||||
Earnings Yield (Greenblatt) % | -94.34 | |||||
FCF Yield % | -6.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:RGNT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Regentis Biomaterials Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.644 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 49.15 | ||
| 14-Day ATR ($) | 0.876626 | ||
| 20-Day SMA ($) | 4.2285 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 1.2316 - 15.5 | ||
| Shares Outstanding (Mil) | 7.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Regentis Biomaterials Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Regentis Biomaterials Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Regentis Biomaterials Ltd Frequently Asked Questions
What is Regentis Biomaterials Ltd(RGNT)'s stock price today?
The current price of RGNT is $2.89. The 52 week high of RGNT is $15.50 and 52 week low is $1.23.
When is next earnings date of Regentis Biomaterials Ltd(RGNT)?
The next earnings date of Regentis Biomaterials Ltd(RGNT) is .
Does Regentis Biomaterials Ltd(RGNT) pay dividends? If so, how much?
Regentis Biomaterials Ltd(RGNT) does not pay dividend.
Guru Commentaries on AMEX:RGNT
No articles.
Press Release
Articles on Regentis Biomaterials Ltd
Headlines
See More- 1
Jun 18, 2026
Regentis Biomaterials to raise $6.5M via private placement
Seeking Alpha • 12:31am
Jun 17, 2026
Why Is Regentis Biomaterials Stock Rising On Wednesday?
Benzinga • 9:40am
Jun 15, 2026
Crude Oil Tumbles Over 5%; Empire State Manufacturing Index Falls In June
Benzinga • 11:01am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers